ReviewJMA journal2025
Big Data Science on T Cell Receptor-mediated Immune Regulation.
Review in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
T cell receptors (TCRs) have a highly diverse sequence pattern resulting from the random recombination of gene components in the thymus. This diversity enables TCRs to distinguish between a wide range of self and non-self-antigens, thereby shaping the reactivity of the acquired immune system. Self-responsiveness arising from impaired TCR-based self-discrimination is a crucial trigger for the development of autoimmune diseases. The immunological importance of TCR research is evident, yet traditional experimental and analytical techniques have not fully captured the vast information contained within the TCR repertoire. However, recent advancements in massive parallel sequencing, efficient library preparation pipelines, single-cell experiment platforms, and genome engineering are poised to transform our understanding of TCR diversity, sparking interest in the field. These advancements have made it possible to "read through" the entire TCR repertoire and partially identify their cognate antigens. In parallel, methods for efficiently analyzing large datasets of comprehensive TCR sequences have also progressed. These innovations in experimental and analytical techniques are leading TCR research in new directions, such as using TCR as a real-time biomarker, exploring the link between TCR and T cell differentiation, and investigating TCR genetic regulation. This review will cover recent updates on big data science related to TCR-mediated immune regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.